Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

GENE Genetic Technologies Ltd

0.00 (0.00%)
Pre Market
Last Updated: 04:00:00
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Genetic Technologies Ltd GENE NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 2.28 04:00:00
Open Price Low Price High Price Close Price Prev Close
more quote information »

Recent News

Date Time Source Heading
5/06/202408:00GLOBEGTG and ‘Wellworks for You’ sign B2B sales & marketing deal..
4/22/202415:00GLOBEGenetic Technologies Announces Closing of US$2 Million..
4/18/202412:17GLOBEGenetic Technologies Announces $2 Million Registered Direct..
4/17/202408:00GLOBENew Precision Oncology Tests to Drive Personalised Therapies..
4/16/202408:00GLOBEGeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year..
4/11/202408:00GLOBEGTG to pilot GeneType in Breast Screen centers across the..
4/08/202408:00GLOBEEVENT - Empowering Women Through Knowledge; Humanise Health..
4/02/202408:05GLOBEGenetic Technologies’ Digital Strategy Ignites Significant..
3/26/202408:00GLOBEGTG Global Collaborations and Innovation Update
3/25/202408:00GLOBEGENE to develop Worlds Most Advanced Comprehensive Risk Test..
2/26/202408:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/15/202408:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/14/202414:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/31/202408:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/31/202408:00GLOBELaunching our most comprehensive test and expanding into new..
1/09/202408:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/05/202408:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/05/202408:00GLOBEGenetic Technologies Regains Compliance with Nasdaq Minimum..
1/05/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
12/28/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/27/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/20/202317:00EDGAR2Form F-3 - Registration statement by foreign private issuers
12/14/202308:00GLOBEGeneType's Groundbreaking Saliva Test Transforms Early..
12/12/202308:00GLOBEGenetic Technologies Limited Announces Ordinary Share..
10/30/202308:00GLOBEGene Business Update: Private Hospital Partnership; Expanded..
10/18/202308:30GLOBEGeneType Predicting Risk of Pancreatic Cancer: Major..
9/27/202309:00GLOBEGTG Signs Precision Medicine Pilot with Australia’s Largest..
9/12/202308:00GLOBEBreakthrough: GeneType for Pancreatic Cancer, Melanoma, and..
9/11/202308:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/11/202308:30GLOBEGENE Positioned at the Forefront of Multi-cancer Clinical..
9/11/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/01/202310:00GLOBEGenetic Technologies Limited and 60 Degrees Pharmaceuticals..
8/30/202308:45GLOBEAnnual Results – Momentum Building on our Commercial Plans
8/09/202308:00GLOBEGenetic Technologies Limited Announces Updated Investor..
7/28/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/28/202308:00GLOBEQuarterly Activities Update: Encouraging Growth for geneType..
7/21/202308:00GLOBEGenetic Technologies Receives Nasdaq Notification Regarding..
5/23/202308:00GLOBEGeneType featured on U.S. National TV to raise Breast Cancer..

Your Recent History

Delayed Upgrade Clock